LENVAT 4MG CAPSULE

Form: Capsules

Pack Size: 30 CAPSULES

Marketed by: NATCO PHARMA LTD (ONCOLOGY DIV)

MRP: ₹2811.71

NATCO PHARMA LTD (ONCOLOGY DIV): Lenvat 4MG Capsule, 30 capsules, salt lenvatinib 4mg. NPPA has revised its MRP from Rs 2,812.50 to Rs 2,811.71 (0% lower) with effect from 09-11-2026; trade rate Rs 2,142.26. Group: multi-kinase inhibitor (targeted therapy). Same salt is also supplied by BPRL, Cipla, Eisai, Glenmark, Hetero and others. Handling/counselling: capsules can be dispersed in water or juice if the patient cannot swallow. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.